Table 2.
GerdQ † score for the subject participating in individually evaluable GERD ‡ single-patient trial.
| Week | Treatment | Total symptoms (score) | 1. Heartburn (score) | 2. Regurgitation (score) | 3. Stomach pain (score) | 4. Nausea (score) | 5. Difficulty sleeping with heartburn/regurgitation | 6. Antacid use |
|---|---|---|---|---|---|---|---|---|
| 1 | A | 12 | 2 | 3 | 0 | 1 | 3 | 3 |
| 2 | B | 11 | 2 | 3 | 0 | 1 | 3 | 2 |
| 3 | A | 12 | 0 | 3 | 1 | 2 | 3 | 3 |
| 4 | B | 13 | 2 | 3 | 1 | 3 | 2 | 2 |
| 5 | B | 11 | 2 | 2 | 1 | 3 | 2 | 1 |
| 6 | B | 5 | 0 | 1 | 1 | 3 | 0 | 0 |
| 7 | A | 7 | 2 | 2 | 0 | 2 | 1 | 0 |
| 8 | A | 10 | 0 | 2 | 3 | 3 | 2 | 0 |
| 9 | A | 6 | 0 | 0 | 3 | 3 | 0 | 0 |
| 10 | A | 10 | 0 | 2 | 3 | 3 | 1 | 1 |
| 11 | B | 8 | 1 | 1 | 3 | 3 | 0 | 0 |
| 12 | B | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 13 | B | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 14 | A | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 15 | B | 12 | 0 | 2 | 3 | 3 | 2 | 2 |
| 16 | A | 8 | 0 | 2 | 3 | 3 | 0 | 0 |
| 17 | A | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 18 | B | 12 | 0 | 2 | 3 | 3 | 2 | 2 |
| 19 | B | 9 | 0 | 2 | 3 | 3 | 0 | 1 |
| 20 | A | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 21 | B | 10 | 0 | 0 | 3 | 3 | 2 | 2 |
| 22 | A | 10 | 0 | 2 | 3 | 3 | 0 | 2 |
| 23 | A | 9 | 0 | 1 | 3 | 3 | 0 | 2 |
| 24 | B | 11 | 0 | 2 | 3 | 3 | 1 | 2 |
A: treatment A (esomeprazole 40 mg AM and 40 mg PM); B: treatment B (esomeprazole 40 mg AM and placebo PM). †GerdQ: gastroesophageal reflux disease questionnaire. ‡GERD: gastroesophageal reflux disease.